Try our mobile app

Dealings in securities by a prescribed officer of the company

Published: 2024-04-23 14:50:24 ET
<<<  go to JSE:ADH company page
ADvTECH Limited
(Incorporated in the Republic of South Africa)
(Registration number 1990/001119/06)
Share code: ADH           ISIN: ZAE000031035
(“ADvTECH” or “the Company”)


DEALINGS IN SECURITIES BY A PRESCRIBED OFFICER OF THE COMPANY


In compliance with the JSE Limited Listings Requirements the following information is disclosed in
respect of dealings in ADvTECH securities by an ADvTECH prescribed officer.


 Name of prescribed officer:                      DL Honey

 Company of which a Prescribed Officer:           ADvTECH Limited

 Type and Class of Securities:                    Ordinary shares

 Nature of transaction:                           On-market sale of shares

 Nature of interest:                              Direct beneficial

 Date of transaction:                             19 April 2024

 Number of securities:                            57 926

 Highest trading price per share:                 R28.05

 Lowest trading price per share:                  R27.90

 Volume weighted average price per share:         R27.99

 Total value of transaction:                      R1 621 159.03

 Clearance to deal:                               Yes



  Name of prescribed officer:                      DL Honey

  Company of which a Prescribed Officer:           ADvTECH Limited

  Type and Class of Securities:                    Ordinary shares

  Nature of transaction:                           On-market sale of shares

  Nature of interest:                              Direct beneficial

  Date of transaction:                             22 April 2024

  Number of securities:                            42 074

  Highest trading price per share:                 R28.20

  Lowest trading price per share:                  R28.00
  Volume weighted average price per share:             R28.11

  Total value of transaction:                          R1 182 678.82

  Clearance to deal:                                   Yes




Johannesburg
23 April 2024
Sponsor: Bridge Capital Advisors Proprietary Limited